Clinical Trials Browser

Small Cell Lung Carcinoma × Platinum × 30 days × Clear all

NCT05403723 2026-02-19

Adaptive SBRT Plus Chemoimmunotherapy for ES-SCLC

Phase 1 Suspended

Lung Neoplasms, Small Cell Lung Carcinoma